RNU6-1061P

Across TCGA pan-cancer cohorts, RNU6-1061P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RNU6-1061P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RNU6-1061P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU6-1061P expression acts as an unfavorable survival marker, although some lineages such as MESO and ACC show a favorable association.

MESO, ACC, and BRCA are the cancer types where RNU6-1061P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Median	All	0.684	0.438	<.001	83	view →
ACC	OS	Tertile	III,IV	0.856	0.470	.009	54	view →
BRCA	DFS	Median	III,IV	0.514	0.463	.012	26	view →
DLBC	OS	Tertile	All	0.473	0.945	.006	18	view →
HNSC	DFS	Tertile	All	0.394	0.608	.027	18	view →
STAD	OS	Tertile	III,IV	0.702	0.371	.021	12	view →
OV	OS	Median	IV	0.635	0.852	.024	12	view →
PCPG	DFS	Tertile	All	0.803	0.959	.004	12	view →
KIRP	DFS	Median	II,III,IV	0.794	0.550	.007	10	view →
GBM	OS	Tertile	All	0.272	0.451	.046	9	view →
CHOL	DFS	Median	II,III,IV	0.111	0.575	.021	6	view →
PAAD	DFS	Quartile	All	0.622	0.391	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RNU6-1061P–MESO (OS)

Open the MESO breakdown →